Selcodebart clinical trials
Also written DISC-0974.
How each study uses selcodebart is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the selcodebart studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- DISC-0974
- 4
Studies by the year they started
4 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Disc Medicine, Inc (4)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test selcodebart.
- May 2027Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPhase 1/2 · Disc Medicine, Inc
Studies
Open first, then newest update. How each study uses selcodebart is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaRecruitingPhase 1/2Disc Medicine, IncNCT05320198Written as DISC-0974
- Study of DISC-0974-201 in Participants With IBD and AnemiaRecruitingPhase 2Disc Medicine, IncNCT07368972Written as DISC-0974
- Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and AnemiaCompletedPhase 1Disc Medicine, IncNCT05745883Written as DISC-0974
- Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy SubjectsCompletedPhase 1Disc Medicine, IncNCT04999527Written as DISC-0974
Codes
What other systems call selcodebart · ClinicalTrials.gg INT018043
- UNII (FDA) TQU847U6D9SELCODEBARTOne source FDA
- NCI Thesaurus C187120SelcodebartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | TQU847U6D9 | SELCODEBART | One source FDA |
| NCI Thesaurus | C187120 | Selcodebart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.